Innospec (IOSP) CEO Patrick Williams receives 18,966-share performance award

Rhea-AI Filing Summary

Innospec Inc. President and CEO Patrick Williams reported an acquisition of company shares through an equity award. On February 16, he received 18,966 shares of common stock at no cash price upon settlement of a performance-based restricted stock unit grant originally awarded on February 27, 2023. Following this grant, his direct holdings increased to 218,655 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Williams Patrick

Role PRESIDENT & CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,966	$0.00	--

Holdings After Transaction: Common Stock — 218,655 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Patrick

(Last) (First) (Middle)

8310 SOUTH VALLEY HIGHWAY

SUITE 350

(Street)

ENGLEWOOD CO 80112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INNOSPEC INC. [ IOSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/16/2026		A		18,966(1)	A	$0.00	218,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of common stock acquired upon settlement of a performance-based restricted stock unit award granted to the reporting person on February 27, 2023.

	Patrick Williams	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innospec (IOSP) report for Patrick Williams?

Innospec reported that President and CEO Patrick Williams acquired 18,966 shares of common stock. The shares were issued at no cash cost upon settlement of a performance-based restricted stock unit award originally granted to him on February 27, 2023.

Was the Innospec (IOSP) CEO share transaction a market purchase or a grant?

The transaction was a grant-related acquisition, not a market purchase. Patrick Williams received 18,966 Innospec shares at a price of $0.00 per share upon settlement of a performance-based restricted stock unit award granted on February 27, 2023.

How many Innospec (IOSP) shares does Patrick Williams hold after this Form 4?

After the reported transaction, Patrick Williams directly holds 218,655 shares of Innospec common stock. This total reflects the addition of 18,966 shares acquired through the settlement of a performance-based restricted stock unit award granted in February 2023.

What is the significance of the performance-based RSU award in the Innospec (IOSP) filing?

The filing explains that the 18,966 shares were acquired upon settlement of a performance-based restricted stock unit award. That award was originally granted to Patrick Williams on February 27, 2023, and converted into common shares when its performance conditions were satisfied.

Did Patrick Williams pay cash for the Innospec (IOSP) shares reported on Form 4?

No cash was paid for these shares. The Form 4 lists a transaction price of $0.00 per share, indicating the 18,966 Innospec shares were received as an equity award settlement rather than purchased in the open market or through a cash transaction.